Aberrant expression of HOXA proteins and the upregulation of HOX cofactor MEIS1 are critical downstream effects in MLL-rearranged AML [120], leading to aberrant differentiation and lineage plasticity [117]. The gene discussed is KMT2A; the disease is acute myeloid leukemia.